Somatostatinoma | Medibuddy
25th May 2025

Somatostatinoma

Somatostatinomas produce excess somatostatin, which is a hormone that inhibits gastrin, CCK, secretin, VIP, insulin, growth hormone and glucagon. They occur in the pancreas, duodenum or jejunum.

Investigations for all rare functional neuroendocrine tumours:

  • Bloods for hormone levels (glucagon, VIP, somatostatin, 5HT)
  • CT/MRI/Endoscopic ultrasound
  • Somatostatin receptor imaging

Management:

  • < 2cm with low grade, asymptomatic disease – may be suitable for surveillance
  • > 2cm – surgical resection
  • Unresectable or distant metastases would need specialist MDT discussion
Mobile app screenshots

Take your subscriptions with you

Our mobile app allows you to access your interview and exam question banks wherever you are.